US Patent 11786578 Modified relaxin polypeptides and their uses
Patent 11786578 was granted and assigned to Ambrx on October, 2023 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11786578 Modified relaxin polypeptides and their uses
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
